KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Assets: 2020-2024

Historic Assets for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2024 value amounting to $1.4 billion.

  • Ginkgo Bioworks Holdings' Assets fell 19.70% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 19.70%. This contributed to the annual value of $1.4 billion for FY2024, which is 17.29% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Assets stood at $1.4 billion for FY2024, which was down 17.29% from $1.7 billion recorded in FY2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Assets peaked at $2.5 billion during FY2022, and registered a low of $675.2 million during FY2020.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Assets value was $1.7 billion (recorded in 2023), while the average stood at $1.9 billion.
  • In the last 5 years, Ginkgo Bioworks Holdings' Assets spiked by 206.74% in 2021 and then crashed by 34.42% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Assets stood at $675.2 million in 2020, then surged by 206.74% to $2.1 billion in 2021, then rose by 22.61% to $2.5 billion in 2022, then crashed by 34.42% to $1.7 billion in 2023, then declined by 17.29% to $1.4 billion in 2024.